First Time Loading...

Teladoc Health Inc
NYSE:TDOC

Watchlist Manager
Teladoc Health Inc Logo
Teladoc Health Inc
NYSE:TDOC
Watchlist
Price: 13.01 USD -2.4% Market Closed
Updated: Apr 28, 2024

EV/EBIT
Enterprise Value to EBIT

-11.8
Current
-24.8
Median
17.2
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-11.8
=
Enterprise Value
2.6B
/
EBIT
-224.5m
All Countries
Close
EBIT Growth
US
Teladoc Health Inc
NYSE:TDOC
Average EV/EBIT: 92.3
Negative Multiple: -11.8
N/A
US
Veeva Systems Inc
NYSE:VEEV
66.1
238%
US
Cerner Corp
NASDAQ:CERN
38.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
111.6
N/A
JP
M3 Inc
TSE:2413
16.4
N/A
AU
Pro Medicus Ltd
ASX:PME
112.7
110%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -162.9 N/A
US
Doximity Inc
NYSE:DOCS
22.9
116%
SE
Sectra AB
STO:SECT B
Negative Multiple: -66.2 N/A
US
Evolent Health Inc
NYSE:EVH
277.7
2 086%
US
Goodrx Holdings Inc
NASDAQ:GDRX
Negative Multiple: -111.3 N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-14.1
2-Years Forward
EV/EBIT
-22
3-Years Forward
EV/EBIT
-1 280.5

See Also

Discover More